argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
623.82
-2.21 (-0.35%)
Dec 20, 2024, 4:00 PM EST - Market closed

argenx SE Revenue

argenx SE had revenue of $588.88M in the quarter ending September 30, 2024, with 73.28% growth. This brings the company's revenue in the last twelve months to $1.91B, up 85.56% year-over-year. In the year 2023, argenx SE had annual revenue of $1.27B with 187.66% growth.

Revenue (ttm)
$1.91B
Revenue Growth
+85.56%
P/S Ratio
n/a
Revenue / Employee
$1,662,595
Employees
1,148
Market Cap
38.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.27B827.59M187.66%
Dec 31, 2022441.01M-87.26M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 202061.96M-30.85M-33.24%
Dec 31, 201992.81M63.58M217.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Takeda Pharmaceutical 31.73B
GE HealthCare Technologies 19.56B
IQVIA Holdings 15.32B
Haleon 15.07B
Alcon 9.76B
Agilent Technologies 6.51B
Edwards Lifesciences 6.31B
ResMed 4.81B
Revenue Rankings